Home
Browse Guidelines
Expert Commentaries
Guideline Syntheses
Guideline Matrix
Guideline Resources
Compare Guidelines
Frequently Asked Questions
Submit Guidelines
About
myNGC
Search within:  

Sort results by:      



Filter results by:

1-11 of 11  
 
1.  
2.  
3.  
Colistimethate sodium and tobramycin dry powders for inhalation for treating pseudomonas lung infection in cystic fibrosis. 2013 Mar. NGC:009746
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
4.  
Mannitol dry powder for inhalation for treating cystic fibrosis. 2012 Nov. NGC:009486
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
5.  
6.  
Practice parameters for the respiratory indications for polysomnography in children. 2011 Mar. NGC:008541
American Academy of Sleep Medicine - Professional Association. View all guidelines by the developer(s)
7.  
8.  
9.  
Best evidence statement (BESt). Cystic fibrosis - effects of massage therapy on quality of life. 2009 May 8. NGC:007252
Cincinnati Children's Hospital Medical Center - Hospital/Medical Center. View all guidelines by the developer(s)
10.  
Pregnancy outcomes after assisted human reproduction. 2006 Mar (revised 2014 Jan). NGC:010292
Society of Obstetricians and Gynaecologists of Canada - Medical Specialty Society. View all guidelines by the developer(s)
11.  
Management of spontaneous pneumothorax: British Thoracic Society pleural disease guideline 2010. 2003 (revised 2010 Aug). NGC:009134
British Thoracic Society - Medical Specialty Society. View all guidelines by the developer(s)
1-11 of 11